Drug Discovery of COPD
Drug discovery for COPD aims to identify new medications that target the underlying mechanisms of the disease, such as inflammation and airflow obstruction. This process involves screening for compounds that can improve lung function, reduce symptoms, and slow disease progression. Advances in drug discovery are essential for developing more effective therapies that can enhance the quality of life for individuals with COPD.
Related Conference of Drug Discovery of COPD
April 27-28, 2026
14th International Conference on COPD Clinical Trials & Lung Care Advances
Paris, Aland Islands
May 14-15, 2026
6th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
June 29-30, 2026
16th International Conference on Pulmonary & Respiratory Medicine
Aix-en-Provence, France
Drug Discovery of COPD Conference Speakers
Recommended Sessions
- Asthma Management
- Asthma-COPD Overlap
- Chronic Obstructive Pulmonary Disease
- Clinical Immunology & Genetics
- Clinical Trials
- COPD Pathogenesis
- COPD Preventative Measures
- Depression and Anxiety in COPD
- Diagnosis and Treatment of COPD
- Drug Discovery of COPD
- Effect of COVID-19 on Lungs
- Epidemiology
- Experimental Models
- Lung and COVID-19
- Lung Transplantation
- Pathophysiology & Pharmacology
- Pharmacological and Non-Pharmacological Treatments
- Pulmonary Rehabilitation
- Respiratory Failure
- Self-Management and Prevention of COPD
- Spirometry
Related Journals
Are you interested in
- Advances in Mechanical Ventilation and Respiratory Support - Pulmonology-2026 (Spain)
- Airway Management Techniques in Critical Care Settings - Pulmonology-2026 (Spain)
- Asthma - Pulmonary Meet 2026 (France)
- Asthma Management: Guidelines and Personalized Therapy - Pulmonology-2026 (Spain)
- Cardiopulmonary Disease - Tuberculosis-2026 (France)
- Chronic Bronchitis - Pulmonary Meet 2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Pulmonary Meet 2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) Updates - Pulmonology-2026 (Spain)
- Climate Change and Respiratory Diseases - Tuberculosis-2026 (France)
- Critical Care Strategies in Sepsis and Multi-Organ Failure - Pulmonology-2026 (Spain)
- Cystic Fibrosis - Pulmonary Meet 2026 (France)
- Drug-Resistant Tuberculosis: - Tuberculosis-2026 (France)
- Early Detection and Diagnosis - Tuberculosis-2026 (France)
- Epidemiology of TB Disease - Tuberculosis-2026 (France)
- Ethical Dilemmas and Decision-Making in ICU Settings - Pulmonology-2026 (Spain)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2026 (France)
- Immunotherapy and Biologics in Respiratory Diseases - Pulmonology-2026 (Spain)
- Infection Control Measures - Tuberculosis-2026 (France)
- Infectious Respiratory Diseases - Pulmonary Meet 2026 (France)
- Innovations in Interventional Pulmonology - Pulmonology-2026 (Spain)
- Integrated Healthcare Approach - Tuberculosis-2026 (France)
- Interstitial Lung Disease (ILD) - Pulmonary Meet 2026 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2026 (France)
- Lung Cancer - Pulmonary Meet 2026 (France)
- Lung Cancer Screening, Diagnosis, and Interventions - Pulmonology-2026 (Spain)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2026 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2026 (France)
- Lung Infection - Tuberculosis-2026 (France)
- Lung Infections: Tuberculosis, Pneumonia, and Beyond - Pulmonology-2026 (Spain)
- Lung Problems - Pulmonary Meet 2026 (France)
- Lung Transplantation - Pulmonary Meet 2026 (France)
- Management of Acute Respiratory Distress Syndrome (ARDS) - Pulmonology-2026 (Spain)
- Multidrug-resistant TB - Tuberculosis-2026 (France)
- Mycobacterial Infections - Tuberculosis-2026 (France)
- Non-Invasive Ventilation in Acute and Chronic Care - Pulmonology-2026 (Spain)
- Nutrition and Tuberculosis - Tuberculosis-2026 (France)
- One Health Approach to TB Control - Tuberculosis-2026 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2026 (France)
- Pediatric Pulmonology and Critical Care Challenges - Pulmonology-2026 (Spain)
- Pediatric Tuberculosis - Tuberculosis-2026 (France)
- Pleural Diseases - Pulmonary Meet 2026 (France)
- Point-of-Care Ultrasound in Critical Care Medicine - Pulmonology-2026 (Spain)
- Post-COVID Pulmonary Complications and Long-Term Care - Pulmonology-2026 (Spain)
- Prevention and Control of Respiratory Diseases - Pulmonary Meet 2026 (France)
- Preventive Therapy - Tuberculosis-2026 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2026 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2026 (France)
- Pulmonary Edema - Tuberculosis-2026 (France)
- Pulmonary Fibrosis and Interstitial Lung Disease - Pulmonology-2026 (Spain)
- Pulmonary Hypertension - Pulmonary Meet 2026 (France)
- Pulmonary Hypertension: Diagnosis and Emerging Therapies - Pulmonology-2026 (Spain)
- Pulmonary Rehabilitation - Pulmonary Meet 2026 (France)
- Pulmonary Rehabilitation and Patient-Centered Recovery - Pulmonology-2026 (Spain)
- Pulmonology - Pulmonary Meet 2026 (France)
- Research and Innovation - Tuberculosis-2026 (France)
- Respiratory Disorders - Pulmonary Meet 2026 (France)
- Respiratory Tract Infections - Pulmonary Meet 2026 (France)
- Role of Imaging in Pulmonary Diagnostics and ICU Care - Pulmonology-2026 (Spain)
- Sleep-Disordered Breathing and CPAP Therapies - Pulmonology-2026 (Spain)
- Sleep-Related Respiratory Disorders - Pulmonary Meet 2026 (France)
- TB Clinical Trials - Tuberculosis-2026 (France)
- TB Vaccines - Tuberculosis-2026 (France)
- TB-HIV Co-Infection: - Tuberculosis-2026 (France)
- TB-HIV Co-infections - Tuberculosis-2026 (France)
- Tuberculosis - Pulmonary Meet 2026 (France)
- Tuberculosis in Vulnerable Populations - Tuberculosis-2026 (France)
- Vaccination Programs: - Tuberculosis-2026 (France)